At Shefaa Al Orman, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2016, the ISO accredited hospital is located in Luxor, Egypt, and has 350 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.